Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07878338
PHASE2

FAPI PET Imaging in Nonischemic Cardiomyopathy

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

This study aims to evaluate the clinical value of \[¹⁸F\]AlF-NOTA-FAPI-04 PET/CT for the noninvasive assessment of myocardial fibroblast activation in patients with nonischemic cardiomyopathy. The study will investigate whether \[¹⁸F\]AlF-NOTA-FAPI-04 PET/CT can provide complementary information for disease phenotyping, assessment of treatment response, and prognostic risk stratification in nonischemic cardiomyopathy.

Official title: Mapping Myocardial Fibroblast Activation With FAPI PET Imaging in Nonischemic Cardiomyopathy

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2025-12-02

Completion Date

2028-12-31

Last Updated

2026-10-16

Healthy Volunteers

No

Interventions

DRUG

[¹⁸F]AlF-NOTA-FAPI-04

An I.V. bolus injection of up to 10 millicurie (mCi) \[¹⁸F\]AlF-NOTA-FAPI-04 will be administered, followed by a PET/CT scan.

Locations (1)

Peking Union Medical College Hospital

Beijing, China